SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Baba Maiyaki Musa, Denny John, Abdulrazaq G. Habib, Andreas Kuznik, Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria, Tropical Medicine & International Health, 2016, 21, 2
  2. 2
    Helen Cox, Lebogang Ramma, Lynne Wilkinson, Virginia Azevedo, Edina Sinanovic, Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa, Tropical Medicine & International Health, 2015, 20, 10
  3. 3
    Yoko V. Laurence, Ulla K. Griffiths, Anna Vassall, Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review, PharmacoEconomics, 2015, 33, 9, 939

    CrossRef

  4. 4
    Merav Kliner, Mamvura Canaan, Sifiso Zwide Ndwandwe, Fred Busulwa, William Welfare, Marty Richardson, John Walley, John Wright, Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study, Infectious Diseases of Poverty, 2015, 4, 1

    CrossRef

  5. 5
    John B. Lynch, Multidrug-resistant Tuberculosis, Medical Clinics of North America, 2013, 97, 4, 553

    CrossRef

  6. 6
    Tolu Oni, Kari Stoever, Robert J Wilkinson, Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority, The Lancet Respiratory Medicine, 2013, 1, 5, 356

    CrossRef